Table 5 Cox proportional hazards model of event-free survival from start of remission for patients who achieved CR after ≥2 salvage attempts (n = 108 patients with 125 attempts)

From: Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study

Variable

Variable levels

Number of events/total

Univariable analysis

Multivariable analysis

HR

95% CI

HR

95% CI

Salvage attempt

Second

52/82

1.0

1.0

Third

24/27

1.99

1.21–3.26

1.78

1.06–2.98

Fourth through eighth

10/16

1.31

0.67–2.60

1.18

0.57–2.44

p-value

 

0.0323

0.1073

Trend p-value

 

0.0906

0.1368

Duration of previous remission

CR not achieved

26/37

0.72

0.40–1.28

0.77

0.40–1.47

CR < 18 m duration

21/29

1.0

1.0

CR 18–36 m duration

12/20

0.61

0.30–1.25

0.71

0.34–1.49

CR ≥ 36 m duration

8/16

0.41

0.18–0.92

0.45

0.19–1.04

Not evaluable for response

19/23

1.16

0.62–2.15

1.20

0.61–2.36

p-value

 

0.1452

0.2807

Trend p-value

 

0.1422

0.2211

NCI risk category at diagnosis

Non-infants, standard risk

39/60

1.0

1.0

Non-infants, high risk

35/46

1.29

0.81–2.02

1.21

0.74–1.97

Non-infants, unknown

11/17

1.08

0.55–2.11

0.96

0.44–2.11

Infants

1/2

p-value

 

0.7440

0.8127

Extramedullary involvement at relapse

No

72/101

1.0

1.0

Yes

14/24

0.67

0.38–1.19

0.71

0.38–1.31

p-value

 

0.1522

0.2644

Subsequent HSCT

No

43/57

1.0

1.0

Yes

43/68

0.73

0.45–1.21

0.76

0.42–1.36

 p-value

 

0.2292

0.3530

BM status at start of attempt

M2 (5–25%)

18/23

1.0

1.0

M3 (over 25%)

68/102

0.90

0.53–1.51

1.14

0.65–1.99

p-value

 

0.6854

0.6500

Cytogenetics

Favorable

17/24

1.0

1.0

Unfavorable

14/21

1.02

0.50–2.07

0.53

0.22–1.28

Other

55/80

1.08

0.68–2.03

1.15

0.63–2.10

p-value

 

0.7802

0.0869

  1. BM bone marrow, CR complete remission, HR hazard ratio, HSCT hematopoietic stem cell transplant. The bold values are the p-values with statstical significance (< 0.05)